EU PROJECTBringing an innovative pocket-sized 12-lead ECG with AI-automated interpretation to the market: AnyECG project. CLINICAL STUDYCardiolyse Risk of Heart Disorders score predicts heart failure outcomes in the MyoVasc study DEVICE INTEGRATIONCardiolyse and MedicubeX deepen their collaboration CLINICAL PILOTPost-ablation telemonitoring with GVM Care & Research at Maria Cecilia Hospital HOSPITAL PILOTCardiolyse improves cardiovascular care at Oxford University Hospitals EU PROJECTCRANE: pre-commercial procurement for remote chronic care

We help clinicians and health care providers prevent heart disease, not just detect it.

Cardiolyse is a CE-certified, device-agnostic ECG analytics platform. We turn signals from any digital ECG source — 12-lead, Holter, patch or wearable — into structured measurements, interpretations and Wellness Risk Scores, covering 30+ arrhythmias and 300+ biomarkers via a secure REST API and web dashboard.

01

Monitor

Cloud infrastructure for real-time remote heart-health monitoring, working with any digital ECG device or wearable.

02

Analyze

Clinically validated AI algorithms extract 300+ biomarkers and classify 30+ arrhythmias across resting and Holter recordings.

03

Predict

Cardiolyse Wellness Risk Scores flag high-risk patients and support early, personalised intervention decisions.

04

Prevent

Personalized reports on vital cardiac parameters help clinicians adjust treatment procedures and lifestyle before events occur.

Terkko Health Hub, Cardiolyse headquarters on the Meilahti campus in Helsinki, Finland

Headquartered in Helsinki

Built inside one of Europe's leading health-tech hubs.

Our headquarters sit inside Terkko Health Hub on the Meilahti campus — the heart of Helsinki's medical research district and a home for clinicians, researchers and health-tech companies working side by side.

  • HQ Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland
  • Focus AI-powered ECG & HRV analytics for clinical and OEM use
  • Approach Device-agnostic · API-first · Explainable AI
Normunds Daudiss, CEO of Cardiolyse, standing with arms crossed in the office.
Normunds Daudiss CEO, Cardiolyse

We’re building toward a future where cardiac intelligence is continuous, scalable and accessible

— helping us understand risk earlier and make better decisions before disease becomes an event.

Team & advisors

A global team of clinical, engineering and regulatory experts.

Behind the Cardiolyse platform is an experienced team combining clinical, commercial and technical depth — supported by an advisory board of practicing cardiologists and healthcare executives.

Management team

  • Portrait of Normunds Daudiss, Chief Executive Officer.

    Chief Executive Officer

    Normunds Daudiss

    Leads commercialisation, fundraising and partnerships — 15+ years turning digital-health innovation into revenue.

  • Portrait of Poornima Soundara Rajan, Chief Technical Officer.

    Chief Technical Officer

    Poornima Soundara Rajan

    Owns the ECG AI platform end-to-end — from signal-processing pipelines to production API and dashboard delivery.

  • Portrait of Iryna Zharuk, Chief Compliance Officer.

    Chief Compliance Officer

    Iryna Zharuk

    Runs quality, regulatory and information-security programmes — keeping the platform audit-ready across ISO 13485, GDPR and NHS DSP.

  • Portrait of Muhammad Uzair Zahid, Head of AI.

    Head of AI

    Muhammad Uzair Zahid

    Designs and validates the deep-learning models behind Cardiolyse arrhythmia detection and biomarker extraction.

Advisory team

  • Portrait of Dr. Massimo Gualerzi, Scientific Advisor.

    Scientific Advisor

    Massimo Gualerzi, MD

    Practicing cardiologist and co-founder of The Longevity Suite — supports Cardiolyse's vision and preventive-cardiology roadmap.

  • Portrait of Cosimo Pulli, Global Development Advisor.

    Global Development Advisor

    Cosimo Pulli

    Pharma and medical-device executive with 25+ years opening international markets — opens doors across EU and global healthcare buyers.

  • Portrait of Emilio Attolini, Business Advisor.

    Business Advisor

    Emilio Attolini

    Telemedicine expert and advisor — advises on go-to-market and medical-device commercialisation.

  • Portrait of Marco Bühler, Strategic Advisor.

    Strategic Advisor

    Marco Bühler

    Leading a global home health and wellbeing company in its fourth generation, supporting strategic direction and execution.

Selected by

Selected by leading European health-innovation programs:

EIT Health Catapult semi-finalist, selected for intensive training, investor introductions and pitch competition.

Selected for the Deloitte Health & Biotech Accelerator from more than 350 international applicants.

Selected for Plug and Play Startup Creasphere, one of Europe’s leading healthcare-innovation platforms.

Featured on Aescuvest’s European health-investment platform.

CRANE PCP was an EU Horizon 2020 Pre-Commercial Procurement project that harnessed health data to help chronic patients move towards self-management, validated with citizens in rural Sweden, Norway and Spain.

AnyECG is revolutionizing cardiac monitoring with a pocket-sized, medical-grade ECG recording device and automated ECG interpretation for use anywhere, at any time, by anyone.

Ready to see Cardiolyse in your workflow?

Talk to our team about integrating AI-powered ECG analytics into your clinical, device or research pipeline.

Book Exploration Call Talk to sales